Online Exclusives

Hovione Planning Ribbon-Cutting at NJ Facility – A Behind-the-Scenes Preview

The company is building out more than 200,000 square feet of space in New Jersey.

Editor’s Take: See some of what’s going on at a newly expanded pharma facility before it officially opens.

In April, Contract Pharma had the opportunity to tour Hovione’s expanded manufacturing facility in East Windsor, NJ. The company is planning a formal ribbon-cutting this fall; before that, we got an inside look at some new features.

Having established United States operations in 2002, Hovione now has more than 200,000 square feet of space in New Jersey. This will be developed into a large, integrated campus in the next five to ten years.

Overall, the company’s recent NJ expansion, which began in 2025, has tripled its total spray-drying capacity in the U.S.

Future Facility Upgrades

A 125,000-square-foot greenfield acquired by Hovione at the East Windsor campus will eventually be a large-scale production site. This includes enhanced quality control and R&D capabilities.

Together, all this adds to Hovione’s stable of manufacturing sites, R&D centers, and other offices spread across three continents.

Key to the expansion is a targeted reduction of Hovione’s carbon footprint by 40% by the year 2030. Part of this goal is embracing new and/or changing solvent types to help meet sustainability standards. Additionally, the company says automation that has been put in place at its Portugal site will be replicated in NJ.

Hovione Aligns NJ Operations

At the Drug, Chemical & Associated Technologies Association (DCAT) Week in New York in March, Contract Pharma met with Hovione. There, David Basile, Vice President of Technical Operations—Americas, further illustrated the New Jersey expansion.

“Hovione aims to build an equivalent manufacturing network, where clients can go to any site across the globe,” Basile said. “The design of the facility has been well-thought through with material flows [and] gravity-fed processes. It’s scalable. We call each one of these building segments a finger. You can copy and paste these fingers, and they are built to house both spray drying and drug product assets.”

Ultimately, with these moves and a strategic partnership model, Hovione aims to provide customers an opportunity to co-invest and access the company’s proprietary knowledge and assets to accelerate programs and create long-term value.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters